• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Oncology

Advent of mammography associated with increased detection of smaller breast tumors

byMatthew Lin, MDandShaidah Deghan, MSc. MD
October 13, 2016
in Oncology, Surgery
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. After advent of mammography, detection rate of large tumors decreases while detection of smaller tumors increases.

2. The decreased rate of large tumor detection was a direct result of increased detection of smaller tumors and not due to a decreased incidence rate.

Evidence Rating Level: 2 (Good)
­

Study Rundown: This retrospective cohort study aimed to evaluate the effectiveness of mammography screening in clinical practice – namely, to assess the mortality benefit vs. the pitfall of potential harm through overdiagnosis. The researchers used data between 1975-2012 from the Surveillance, Epidemiology and End Results (SEER), a population-based registry of cancer incidence in the United States. Their study demonstrated that after screening mammography became widely introduced between the years of 1982-1990, there was an increase in the detection of small invasive tumors compared to large carcinomas. In assessing the relative risk of 10-year mortality in breast cancers by size, those that were >2cm had comparatively higher risks. The authors concluded that the rate of detection of large tumors likely decreased after the advent of screening mammography due the increased detection of smaller tumors, translating into a presumed reduction of mortality. However, it was felt that the increase in detection of small tumors, assuming a stable underlying disease burden, may have also represented an increase in overdiagnosis.

Click to read the study, published today in NEJM

Relevant Reading: Biology before anatomy in early breast cancer – precisely the point

RELATED REPORTS

Historical redlining associated with lower breast cancer screening across urban neighborhoods

Breast cancer screening with MRI provides modest benefit for high-risk women

FDA approvedFor breast cancer: Etcamah (camizestrant), Sep 4, 2026→

In-Depth [retrospective cohort]: Researchers performed analyses on SEER data for women ≥40 years of age. They classified tumor size and calculated the 10-year risk of death based on tumor size stratification. After screening mammography was introduced, proportion of detected small invasive tumors (<2 cm or in situ carcinomas) increased from 36% to 65% while the proportion of detected large carcinomas decreased from 64% to 32% between 1975-2012. Prior to mammography, the incidence of large tumors predominated. There was an overall 1.8x fold increase in the detection of small invasive tumors (<2cm, or in situ carcinomas), compared to a 2x fold decrease in the detection rates of large carcinomas. The incidence of large tumors decreased by 30 cases/100,000 women (from 145 to 115) and the incidence of small tumors increased by 162 cases/100,000 women (from 82 to 244). Under the assumption that the burden of clinically significant breast cancer remained unchanged throughout this time, the authors inferred that these 30 cases/100,000 women were likely to become large tumors, while the remaining 132 represented overdiagnoses. In terms of mortality, reduction in mortality due to mammography was approximately 12 deaths/100,000 women. In terms of 10-year risk of death from breast cancer in large tumors, the relative risk for tumors ≥5.0cm, tumors between 3.0-4.9cm and 2.0-29cm was 0.79 (95%CI 0.74-0.84), 0.70 (95%CI 0.65-0.75) and 0.58 (95%CI 0.53-0.62), respectively. For small tumors, the relative risk for tumors <1.0cm and tumors between 1.0-1.9cm was 0.26 (95%CI 0.21-0.32) and 0.38 (95%CI 0.34-0.42).

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: breast cancer screening
Previous Post

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Next Post

Improving heat-shock protein levels shows efficacy against lysosomal storage diseases [PreClinical]

RelatedReports

A middle-aged woman looks thoughtfully at an abstract representation of cells and a statin pill, symbolizing breast cancer and medication usage.
Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
Breast cancer MRI screening collage: an empty MRI scanner with its table extended and a white camellia resting on it
Oncology

Breast cancer screening with MRI provides modest benefit for high-risk women

March 2, 2026
Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

June 25, 2025
Chronic Disease

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

April 2, 2025
Next Post

Improving heat-shock protein levels shows efficacy against lysosomal storage diseases [PreClinical]

Similar prostate cancer mortality with surgery, radiation, and active surveillance: The ProtecT trial

Casting versus surgery for ankle fractures in older adults

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • AI Model Shows Promise in Predicting PTSD Risk Following Trauma
  • 2 Minute Medicine Rewind November 16, 2026
  • ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.